Birinapant Sensitizes Platinum-Resistant Carcinomas With High Levels of cIAP to Carboplatin Therapy

Gynecologic Oncology- United States

doi 10.1016/j.ygyno.2017.03.062

Full Text

Abstract

Available in

Date

Authors

Publisher

Elsevier BV

Related search

Editorial Expression of Concern: Birinapant Sensitizes Platinum-Resistant Carcinomas With High Levels of cIAP to Carboplatin Therapy

npj Precision Oncology
2018English

816 Autophagy Inhibition Sensitizes Targeted Therapy-Resistant Melanoma to MEK1/2 Inhibitors

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Evaluation of Novel Ammine/Amine Platinum (IV) Dicarboxylates in L1210 Murine Leukaemia Cells Sensitive and Resistant to Cisplatin, Tetraplatin or Carboplatin

British Journal of Cancer
Cancer ResearchOncology
1994English

Prm212 - Patient Experience With Platinum-Resistant or Platinum-Refractory Ovarian Cancer

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

BRAF Targeting Sensitizes Resistant Melanoma to Cytotoxic T Cells

Clinical Cancer Research
Cancer ResearchOncology
2019English

Advanced Seminoma: Treatment With Cis-Platinum-Based Combination Chemotherapy or Carboplatin (JM8)

British Journal of Cancer
Cancer ResearchOncology
1985English

mTORC1/2 Inhibition Re-Sensitizes Platinum-Resistant Ovarian Cancer by Disrupting Selective Translation of DNA Damage and Survival mRNAs

Oncotarget
Oncology
2018English

Docetaxel as Salvage Therapy in Highly Pretreated and Drug Resistant Gastrointestinal Carcinomas

Clinical medicine. Oncology
2008English

ATM Inhibition Sensitizes Tumors to High-Dose Irradiation

Cancer Research
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy